Quality, innovations and statistics · 2 steps
Patient selection in theranostics
Radioligand therapy only treats lesions that show the target on imaging; a single lesion without the target (discordant) can decide the patient's outcome.
Left: an SSTR PET schematic with liver lesions whose uptake rises, and PSMA and FDG PET schematics of the same patient. Right: the Krenning scale comparing lesion SUV with liver and spleen, and a lesion table with the VISION and TheraP selection criteria.
Radioligand therapy only treats lesions that show the target on imaging; a single lesion without the target (discordant) can decide the patient's outcome.
Source: modified Krenning score SNMMI/EANM 2023 (Hope et al., J Nucl Med 2023); PRRT threshold EANM/IAEA/SNMMI 2026 (Bodei et al.); discordance from the book (28.1); VISION selection criterion Sartor et al., NEJM 2021; TheraP criterion Hofman et al., Lancet 2021. Organ and lesion SUVs representative.
How to use: a single click on the drawing pauses and resumes; in the PSMA/FDG step ↑ ↓ or the buttons below change the scenario; use the time bar below to go to any moment; ← → change steps.
Presentation mode ↗The animation alone, sized for full screen; for projecting in lectures and talks. ← → step, space plays/pauses.
Embed
Paste this code into your own page (course site, slides, learning platform). The animation arrives working, with its source written underneath.
In the book
In the book this animation runs in place of these figures: